145 related articles for article (PubMed ID: 15629626)
1. Predictors of radiation pneumonitis after radiotherapy in lung cancer.
Jeremic B; Hennig M; Zimmermann FB
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):302. PubMed ID: 15629626
[No Abstract] [Full Text] [Related]
2. In regard to De Jaeger et al.: significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer (INT J RADIAT ONCOL BIOL PHYS 2004;58:1378-1387).
Anscher MS; Kong FM
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1276-7. PubMed ID: 15752910
[No Abstract] [Full Text] [Related]
3. In response to Drs. Anscher and Kong.
De Jaeger K; Seppenwoolde Y; Lebesque JV; Kampinga HH
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):308. PubMed ID: 16111602
[No Abstract] [Full Text] [Related]
4. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients.
Novakova-Jiresova A; Van Gameren MM; Coppes RP; Kampinga HH; Groen HJ
Radiother Oncol; 2004 May; 71(2):183-9. PubMed ID: 15110452
[TBL] [Abstract][Full Text] [Related]
6. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192
[TBL] [Abstract][Full Text] [Related]
7. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.
Mehta V
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):5-24. PubMed ID: 15963660
[TBL] [Abstract][Full Text] [Related]
8. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
[TBL] [Abstract][Full Text] [Related]
10. Regarding predicting radiation response.
Lawrence TS; Hayman J; Martel M; Ten Haken RK
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):972-3. PubMed ID: 9652868
[No Abstract] [Full Text] [Related]
11. Non-small cell lung cancer: the role of cytoprotection in treating therapy-related toxicity.
Gopal R
J Support Oncol; 2004; 2(6 Suppl 3):13-7. PubMed ID: 15605920
[TBL] [Abstract][Full Text] [Related]
12. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.
Tsougos I; Nilsson P; Theodorou K; Kjellén E; Ewers SB; Jarlman O; Lind BK; Kappas C; Mavroidis P
Phys Med Biol; 2007 Feb; 52(4):1055-73. PubMed ID: 17264370
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of whether radiation pneumonitis is influenced by low-dose irradiated lung volume in primary lung cancer with chronic pulmonary disease.
Niibe Y; Hayakawa K; Masuda N; Yoshimura H
Gan To Kagaku Ryoho; 2007 Feb; 34(2):213-6. PubMed ID: 17301529
[TBL] [Abstract][Full Text] [Related]
14. Determination of TGF-beta1 plasma levels: In regard to Anscher et al. (Int J Radiat Oncol Biol Phys 2003;56: 988-995) and de Jaeger et al (Int J Radiat Oncol Biol Phys 2004;58: 1378-1387).
Barthelemy-Brichant N
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1339; author reply 1339-40. PubMed ID: 15519811
[No Abstract] [Full Text] [Related]
15. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
Yorke ED; Jackson A; Rosenzweig KE; Braban L; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):672-82. PubMed ID: 15939548
[TBL] [Abstract][Full Text] [Related]
16. An improved model for predicting radiation pneumonitis incorporating clinical and dosimetric variables.
Jenkins P; Watts J
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1023-9. PubMed ID: 21543165
[TBL] [Abstract][Full Text] [Related]
17. Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis.
Anscher MS; Murase T; Prescott DM; Marks LB; Reisenbichler H; Bentel GC; Spencer D; Sherouse G; Jirtle RL
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):671-6. PubMed ID: 7928499
[TBL] [Abstract][Full Text] [Related]
18. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters.
Hope AJ; Lindsay PE; El Naqa I; Alaly JR; Vicic M; Bradley JD; Deasy JO
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):112-24. PubMed ID: 16618575
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 in serum and induced sputum for predicting radiation pneumonitis in patients with non-small cell lung cancer after radiotherapy.
Wang J; Qiao XY; Lu FH; Zhou ZG; Song YZ; Huo JJ; Liu X
Chin J Cancer; 2010 Mar; 29(3):325-9. PubMed ID: 20193119
[TBL] [Abstract][Full Text] [Related]
20. Association between white blood cell count following radiation therapy and radiation pneumonitis in non-small cell lung cancer. In regard to Tang et al.
Cengel KA; Simone CB
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):240. PubMed ID: 25195998
[No Abstract] [Full Text] [Related]
[Next] [New Search]